Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
This medicine contains a combination of plant extracts.
Drug based on avocado and soy unsaponifiables indicated in the symptomatic treatment (pain and discomfort during movements) with delayed effect of osteoarthritis of the knee (Requires a medical diagnosis).
PIASCLÉDINE 300 box of 90 capsules
Also available in boxes of 30 capsules and 60 capsules
| p capsules | |
| Unsaponifiables of avocado oil | 100 mg |
| Unsaponifiables of soybean oil | 200 mg |
Active ingredients: Unsaponifiables of avocado oil, Unsaponifiables of soya oil
Excipients: Butylated hydroxytoluene, Erythrosine, Yellow iron oxide, Gelatin, Polysorbate 80, Colloidal anhydrous silica, Titanium dioxide
The effect of this drug during pregnancy or lactation is not known. The evaluation of the possible risk related to its use is individual: ask your pharmacist or your doctor for advice.
The capsules should be swallowed with a glass of water, in the middle of meals.
1 capsule per day.
In the treatment of osteoarthritis, the effect of this medication is slow to appear: relief generally appears only after 1 to 2 months of treatment.
The drug treatment does not dispense with measures to fight against possible overweight. It is also recommended to practice an adapted physical activity to strengthen the muscles and maintain the mobility of the joint.
Rare regurgitation with a lipidic smell, allergic reaction.
Diarrhea, stomach pain.
Exceptionally: liver damage.
If you have experienced an adverse reaction that may be due to this medicine, you can report it by downloading the form.
See the Piascledine® 300 leaflet in the "Attached documents" tab
Specific References
Indicated in the symptomatic treatment of osteoarthritis.
Injection treatment of mild to moderate osteoarthritis of the knee or hip.
DUROLANE® has also been approved for the symptomatic treatment associated with mild to moderate osteoarthritis pain of the ankles, shoulders, elbows, wrists, fingers and toes.
Pain relief improves joint function and helps restore quality of life.
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.
Flect'Expert Patch Harpagophytum unties, softens and relieves immediately the joint and muscle tensions of everyday life by providing a warm effect.
Indications: STRUCTUM is used in adults (over 15 years of age) for the treatment of pain and functional discomfort in osteoarthritis of the knee and hip. This drug has a slow onset of action, delayed by about 2 months, and its effect may persist after treatment has been stopped.
A cream to soothe and limit joint pain Designed to relieve lower back pain, this warming cream has anti-inflammatory and moisturizing properties. It provides a sensation of warmth that helps relax muscles and joints. Mobility improves day by day with regular application.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Indication: Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy related to joint alterations
Arthrum HCS 40mg/2ml is indicated for all types of painful synovial joint arthritis, particularly gonarthrosis.
Arthrum HCS is biologically similar to human synovial fluid and participates in the following functions: Protect the cartilage, Protect the synovial membrane, Reduce pain and improve mobility
Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
Français
English
